Skip to main content
Top
Published in: Endocrine 2/2015

01-06-2015 | Endocrine Methods and Techniques

A comprehensive score to diagnose Hashimoto’s thyroiditis: a proposal

Authors: Giorgio Grani, Giovanni Carbotta, Angela Nesca, Mimma D’Alessandri, Martina Vitale, Marianna Del Sordo, Angela Fumarola

Published in: Endocrine | Issue 2/2015

Login to get access

Abstract

The heterogeneity of diagnostic criteria of Hashimoto’s thyroiditis leads to overdiagnosis and prevents strong conclusions from being drawn in clinical studies. The aim of this study is to propose a comprehensive scoring system. A case–control study compared a set of presurgical features of patients with lymphocytic infiltration of the thyroid (Hashimoto’s thyroiditis) and controls, in order to design a multi-criteria scoring system. Given a dichotomous outcome (lymphocytic infiltration of the thyroid), a set of covariates was analyzed in 180 patients after total thyroidectomy. A different validation cohort of 1,171 patients was reviewed and classified according to the score. Variables associated with the diagnosis of Hashimoto’s thyroiditis were first assessed by univariate analysis. Analysis showed that TPOAb (area under the ROC curve (AUC), 0.67; 95 % CI 0.57–0.77) and TgAb (0.63; 95 % CI 0.54–0.74) were univariate predictors of the diagnosis of HT, which is largely recognized. Combined covariates were then tested using stepwise logistic regression analysis. The final regression model included TPOAb, TgAb, and thyroid vascularity (AUC 0.72; 95 % CI 0.62–0.81). A scoring system was developed, which has a sensitivity of 45.5 % and a specificity of 89.0 %, with a cutoff of 1.7. The likelihood of incident hypothyroidism was higher (OR 2.30; p = 0.004) in the positive (≥1.7) score group. A scoring system has a better performance than any single predictor and is able to identify the subgroup of individuals at higher risk to develop subsequent hypothyroidism.
Appendix
Available only for authorised users
Literature
1.
go back to reference D.S.A. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine 42, 252–265 (2012)CrossRefPubMed D.S.A. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine 42, 252–265 (2012)CrossRefPubMed
2.
go back to reference P. Caturegli, A. De Remigis, N.R. Rose, Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun. Rev. 13, 391–397 (2014)CrossRefPubMed P. Caturegli, A. De Remigis, N.R. Rose, Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun. Rev. 13, 391–397 (2014)CrossRefPubMed
3.
go back to reference R. Ahmed, S. Al-Shaikh, M. Akhtar, Hashimoto thyroiditis: a century later. Adv. Anat. Pathol. 19, 181–186 (2012)CrossRefPubMed R. Ahmed, S. Al-Shaikh, M. Akhtar, Hashimoto thyroiditis: a century later. Adv. Anat. Pathol. 19, 181–186 (2012)CrossRefPubMed
4.
go back to reference D.S.A. McLeod, P. Caturegli, D.S. Cooper, P.G. Matos, S. Hutfless, Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel. JAMA 311, 1563–1565 (2014)CrossRefPubMed D.S.A. McLeod, P. Caturegli, D.S. Cooper, P.G. Matos, S. Hutfless, Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel. JAMA 311, 1563–1565 (2014)CrossRefPubMed
5.
go back to reference S. Benvenga, F. Trimarchi, Changed presentation of Hashimoto’s thyroiditis in North-Eastern Sicily and Calabria (Southern Italy) based on a 31-year experience. Thyroid 18, 429–441 (2008)CrossRefPubMed S. Benvenga, F. Trimarchi, Changed presentation of Hashimoto’s thyroiditis in North-Eastern Sicily and Calabria (Southern Italy) based on a 31-year experience. Thyroid 18, 429–441 (2008)CrossRefPubMed
6.
go back to reference M.H. Rho, D.W. Kim, H.P. Hong, Y.M. Park, M.J. Kwon, S.J. Jung, Y.W. Kim, T. Kang, Diagnostic value of antithyroid peroxidase antibody for incidental autoimmune thyroiditis based on histopathologic results. Endocrine 42, 647–652 (2012)CrossRefPubMed M.H. Rho, D.W. Kim, H.P. Hong, Y.M. Park, M.J. Kwon, S.J. Jung, Y.W. Kim, T. Kang, Diagnostic value of antithyroid peroxidase antibody for incidental autoimmune thyroiditis based on histopathologic results. Endocrine 42, 647–652 (2012)CrossRefPubMed
7.
go back to reference A. Willms, D. Bieler, H. Wieler, D. Willms, K.P. Kaiser, R. Schwab, Correlation between sonography and antibody activity in patients with Hashimoto thyroiditis. J. Ultrasound Med. 32, 1979–1986 (2013)CrossRefPubMed A. Willms, D. Bieler, H. Wieler, D. Willms, K.P. Kaiser, R. Schwab, Correlation between sonography and antibody activity in patients with Hashimoto thyroiditis. J. Ultrasound Med. 32, 1979–1986 (2013)CrossRefPubMed
8.
go back to reference M. Rotondi, F. Coperchini, F. Magri, L. Chiovato, Serum-negative autoimmune thyroiditis: what’s in a name? J. Endocrinol. Invest. 37, 589–591 (2014)CrossRefPubMed M. Rotondi, F. Coperchini, F. Magri, L. Chiovato, Serum-negative autoimmune thyroiditis: what’s in a name? J. Endocrinol. Invest. 37, 589–591 (2014)CrossRefPubMed
9.
go back to reference A.M. Harvey, L.D. Truong, D.R. Mody, Diagnostic pitfalls of Hashimoto’s/lymphocytic thyroiditis on fine-needle aspirations and strategies to avoid overdiagnosis. Acta Cytol. 56, 352–360 (2012)CrossRefPubMed A.M. Harvey, L.D. Truong, D.R. Mody, Diagnostic pitfalls of Hashimoto’s/lymphocytic thyroiditis on fine-needle aspirations and strategies to avoid overdiagnosis. Acta Cytol. 56, 352–360 (2012)CrossRefPubMed
10.
go back to reference G. Grani, A. Calvanese, G. Carbotta, M. D’Alessandri, A. Nesca, M. Bianchini, M. Del Sordo, M. Vitale, A. Fumarola, Thyroid autoimmunity and risk of malignancy in thyroid nodules submitted to fine-needle aspiration cytology. Head Neck (2013). doi:10.1002/hed.23587 G. Grani, A. Calvanese, G. Carbotta, M. D’Alessandri, A. Nesca, M. Bianchini, M. Del Sordo, M. Vitale, A. Fumarola, Thyroid autoimmunity and risk of malignancy in thyroid nodules submitted to fine-needle aspiration cytology. Head Neck (2013). doi:10.​1002/​hed.​23587
11.
go back to reference M.G. Castagna, V. Belardini, S. Memmo, F. Maino, A. Di Santo, P. Toti, A. Ferdinando Carli, G. Caruso, F. Pacini, Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series, but not in cytological series: evidence for selection bias. J. Clin. Endocrinol. Metab. (2014). doi:10.1210/jc.2014-1302 PubMed M.G. Castagna, V. Belardini, S. Memmo, F. Maino, A. Di Santo, P. Toti, A. Ferdinando Carli, G. Caruso, F. Pacini, Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series, but not in cytological series: evidence for selection bias. J. Clin. Endocrinol. Metab. (2014). doi:10.​1210/​jc.​2014-1302 PubMed
12.
go back to reference K. Mukasa, J.Y. Noh, Y. Kunii, M. Matsumoto, S. Sato, S. Yasuda, M. Suzuki, K. Ito, K. Ito, Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases. Thyroid 21, 37–41 (2011)CrossRefPubMed K. Mukasa, J.Y. Noh, Y. Kunii, M. Matsumoto, S. Sato, S. Yasuda, M. Suzuki, K. Ito, K. Ito, Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases. Thyroid 21, 37–41 (2011)CrossRefPubMed
13.
go back to reference E. Fiore, T. Rago, F. Latrofa, M.A. Provenzale, P. Piaggi, A. Delitala, M. Scutari, F. Basolo, G. Di Coscio, L. Grasso, A. Pinchera, P. Vitti, Hashimoto’s thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with l-thyroxine. Endocr. Relat. Cancer 18, 429–437 (2011)CrossRefPubMed E. Fiore, T. Rago, F. Latrofa, M.A. Provenzale, P. Piaggi, A. Delitala, M. Scutari, F. Basolo, G. Di Coscio, L. Grasso, A. Pinchera, P. Vitti, Hashimoto’s thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with l-thyroxine. Endocr. Relat. Cancer 18, 429–437 (2011)CrossRefPubMed
14.
go back to reference G. Grani, A. Nesca, M. Del Sordo, A. Calvanese, G. Carbotta, M. Bianchini, A. Fumarola, Interpretation of serum calcitonin in patients with chronic autoimmune thyroiditis. Endocr. Relat. Cancer 19, 345–349 (2012)CrossRefPubMed G. Grani, A. Nesca, M. Del Sordo, A. Calvanese, G. Carbotta, M. Bianchini, A. Fumarola, Interpretation of serum calcitonin in patients with chronic autoimmune thyroiditis. Endocr. Relat. Cancer 19, 345–349 (2012)CrossRefPubMed
15.
go back to reference G. Karanikas, A. Moameni, C. Poetzi, G. Zettinig, K. Kaserer, C. Bieglmayer, B. Niederle, R. Dudczak, C. Pirich, Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J. Clin. Endocrinol. Metab. 89, 515–519 (2004)CrossRefPubMed G. Karanikas, A. Moameni, C. Poetzi, G. Zettinig, K. Kaserer, C. Bieglmayer, B. Niederle, R. Dudczak, C. Pirich, Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J. Clin. Endocrinol. Metab. 89, 515–519 (2004)CrossRefPubMed
16.
go back to reference G. Grani, P. Dicorato, M. Dainelli, I. Coletta, A. Calvanese, M. Del Sordo, A. De Cesare, F.M. Di Matteo, V. D’Andrea, A. Fumarola, Thyroid diseases in women with breast cancer. Clin. Ter. 163, e401–e404 (2012)PubMed G. Grani, P. Dicorato, M. Dainelli, I. Coletta, A. Calvanese, M. Del Sordo, A. De Cesare, F.M. Di Matteo, V. D’Andrea, A. Fumarola, Thyroid diseases in women with breast cancer. Clin. Ter. 163, e401–e404 (2012)PubMed
17.
go back to reference I. Muller, A. Pinchera, E. Fiore, V. Belardi, V. Rosellini, E. Giustarini, C. Giani, High prevalence of breast cancer in patients with benign thyroid diseases. J. Endocrinol. Invest. 34, 349–352 (2011)CrossRefPubMed I. Muller, A. Pinchera, E. Fiore, V. Belardi, V. Rosellini, E. Giustarini, C. Giani, High prevalence of breast cancer in patients with benign thyroid diseases. J. Endocrinol. Invest. 34, 349–352 (2011)CrossRefPubMed
18.
go back to reference S. Benvenga, C.L. Burek, M. Talor, N.R. Rose, F. Trimarchi, Heterogeneity of the thyroglobulin epitopes associated with circulating thyroid hormone autoantibodies in hashimoto’s thyroiditis and non-autoimmune thyroid diseases. J. Endocrinol. Invest. 25, 977–982 (2002)CrossRefPubMed S. Benvenga, C.L. Burek, M. Talor, N.R. Rose, F. Trimarchi, Heterogeneity of the thyroglobulin epitopes associated with circulating thyroid hormone autoantibodies in hashimoto’s thyroiditis and non-autoimmune thyroid diseases. J. Endocrinol. Invest. 25, 977–982 (2002)CrossRefPubMed
19.
go back to reference F. Latrofa, D. Ricci, L. Montanelli, M.A. Altea, A. Pucci, A. Pinchera, P. Vitti, Thyroglobulin autoantibodies of patients with subacute thyroiditis are restricted to a major B cell epitope. J. Endocrinol. Invest. 35, 712–714 (2012)CrossRefPubMed F. Latrofa, D. Ricci, L. Montanelli, M.A. Altea, A. Pucci, A. Pinchera, P. Vitti, Thyroglobulin autoantibodies of patients with subacute thyroiditis are restricted to a major B cell epitope. J. Endocrinol. Invest. 35, 712–714 (2012)CrossRefPubMed
20.
go back to reference P.N. Taylor, A. Iqbal, C. Minassian, A. Sayers, M.S. Draman, R. Greenwood, W. Hamilton, O. Okosieme, V. Panicker, S.L. Thomas, C. Dayan, Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern Med. 174, 32–39 (2014)CrossRefPubMed P.N. Taylor, A. Iqbal, C. Minassian, A. Sayers, M.S. Draman, R. Greenwood, W. Hamilton, O. Okosieme, V. Panicker, S.L. Thomas, C. Dayan, Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. JAMA Intern Med. 174, 32–39 (2014)CrossRefPubMed
Metadata
Title
A comprehensive score to diagnose Hashimoto’s thyroiditis: a proposal
Authors
Giorgio Grani
Giovanni Carbotta
Angela Nesca
Mimma D’Alessandri
Martina Vitale
Marianna Del Sordo
Angela Fumarola
Publication date
01-06-2015
Publisher
Springer US
Published in
Endocrine / Issue 2/2015
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0441-5

Other articles of this Issue 2/2015

Endocrine 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.